Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | L3MBTL1 | Q9Y468 | 3/20 | 0.43 |
| ▸ | MEN1 | O00255 | 2/20 | 0.40 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.40 |
| ▸ | APP | P05067 | 2/20 | 0.40 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.40 |
| ▸ | CA12 | O43570 | 1/20 | 0.39 |
| ▸ | CA1 | P00915 | 1/20 | 0.39 |
| ▸ | CA2 | P00918 | 1/20 | 0.39 |
| ▸ | CA7 | P43166 | 1/20 | 0.39 |
| ▸ | CA9 | Q16790 | 1/20 | 0.39 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.39 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.39 |
| ▸ | POLB | P06746 | 2/20 | 0.38 |
| ▸ | HPGD | P15428 | 1/20 | 0.38 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.38 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.38 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.38 |
| ▸ | EGFR | P00533 | 1/20 | 0.38 |
| ▸ | ALPL | P05186 | 1/20 | 0.36 |
| ▸ | ALPI | P09923 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12557372 | 0.94 | L3MBTL1 (0.39) | L3MBTL1MEN1KMT2AAPPALDH1A1 | |
| SCHEMBL16229625 | 0.88 | L3MBTL1 (0.47) | L3MBTL1MEN1KMT2AAPPALDH1A1 | |
| SCHEMBL2608352 | 0.87 | CA12 (0.50) | L3MBTL1MEN1KMT2AAPPALDH1A1 | |
| SCHEMBL16229673 | 0.86 | L3MBTL1 (0.47) | L3MBTL1MEN1KMT2AAPPALDH1A1 | |
| SCHEMBL12557359 | 0.84 | PTGS2 (0.52) | L3MBTL1MEN1KMT2AALDH1A1CA12 | |
| SCHEMBL16199454 | 0.84 | PTGS2 (0.56) | L3MBTL1MEN1KMT2AAPPALDH1A1 | |
| SCHEMBL12590051 | 0.84 | L3MBTL1 (0.47) | L3MBTL1MEN1KMT2AAPPALDH1A1 | |
| SCHEMBL12557382 | 0.83 | L3MBTL1 (0.47) | L3MBTL1MEN1KMT2AAPPALDH1A1 | |
| SCHEMBL12590027 | 0.82 | L3MBTL1 (0.43) | L3MBTL1MEN1KMT2AAPPALDH1A1 | |
| SCHEMBL16229590 | 0.82 | L3MBTL1 (0.41) | L3MBTL1MEN1KMT2AAPPALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8871977-B2 | Asymmetric azine compound and method for producing the same | ZEON CORPORATION (JP) | 2014-10-28 | — | — | US | disclosed |
| US-20110144379-A1 | ASYMMETRIC AZINE COMPOUND AND METHOD FOR PRODUCING THE SAME | ZEON CORPORATION (JP) | 2011-06-16 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110144379-A1 | ASYMMETRIC AZINE COMPOUND AND METHOD FOR PRODUCING THE SAME | ADH5, ADH1C, ADH1A | L3MBTL1 3826/4885MEN1 1216/4885KMT2A 1080/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.